Does Oral Cholecystographic Contrast Agents Interact with Iodixanol?
Oral Cholecystographic Contrast Agents and Iodixanol have a major drug interaction according to U.S. FDA drug labeling data. Renal toxicity reported in patients with liver dysfunction receiving oral cholecystographic agent followed by iodixanol. Postpone iodixanol administration in patients who recently received oral cholecystographic contrast. The mechanism involves renal toxicity, particularly in hepatic dysfunction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Iodixanol Class
- Radiographic Contrast Agent
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Oral Cholecystographic Contrast Agents and Iodixanol occurs because renal toxicity, particularly in hepatic dysfunction. Clinically, this means renal toxicity reported in patients with liver dysfunction receiving oral cholecystographic agent followed by iodixanol. postpone iodixanol administration in patients who recently received oral cholecystographic contrast. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Oral Cholecystographic Contrast Agents and your doctor is considering prescribing Iodixanol (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider